Tobacco (93) Q5. What are the pros and cons of vaping? (17)

30 March, 2023

Thanks Neil. You asked me, Eduardo and Chris to comment on take home messages about vaping. I thought I'd do one list of all take-home messages about tobacco and nicotine as it's hard to separate.

Take-home messages from me (developed over time and influenced by expert colleagues from the NHS in London and also IPCRG):

- Nicotine dependence is a long-term relapsing treatable condition that often starts in childhood.

- It includes cigarette smoking, use of chewed tobacco, hookah and now e-cigarettes

- It is the nicotine that is addictive but the other substances that cause most harm eg tobacco smoke.

- It is therefore best to never start. Policy measures are most effective and are the WHO "best buys" (in the WHO MPOWER framework these are P = protect; W = warn; E = enforce bans on tobacco advertising, promotion and sponsorship; and R: raise taxes on tobacco).

- However, the O is also important for those already dependent. O= offer help to quit. and the M - monitor.

- Without treatment, up to 2/3 of those who are tobacco dependent will die of this dependence from a huge range of conditions including cancer, chronic respiratory diseases and heart disease (see earlier posts). Typically the more "pack years" the worse the outcome (20 cigarettes = 1 pack; 52 packs = 1 pack year)

- People with severe mental illness have often had the highest pack years and die up to 20 years prematurely compared to the general population (see earlier posts)

- All those who are dependent will also have worse quality of life. Breathlessness, cough, fatigue are common problems. The different products affect different parts of the body more - eg chewed tobacco causes oral cancer, smoking causes lung cancer and chronic obstructive pulmonary disease (COPD).

- The good news is it is treatable: the best evidence suggests pharmacotherapy + counselling.

- In terms of pharmacotherapy, the WHO Essential Medicines List includes Nicotine Replacement Therapy (long-acting patch that deals with nicotine withdrawal and short-acting gum that deals with cravings; there are other types of NRT that may be preferred but these aren't on the WHO List); varenicline (safe and effective but currently has supply issues - look out for generic varenicline) and buproprion (tends to need more monitoring)

- Clinicians (all disciplines) therefore have a duty to diagnose and treat it.

- Consider the Number Needed to Treat to have an impact - avoid premature death - (NNT) for treating tobacco dependence using varenicline + behavioural support is about 20. And typically treatment is needed for up to 6 months. Compare this to antihypertensive treatment for mild hypertension to avoid one stroke or MI death over 1 year is 700. https://www.nature.com/articles/s41533-017-0039-5/tables/2

- With limited time, use Very Brief Advice - models such as Every Contact Counts means that there should be the same message given whichever healthcare professional the dependent person encounters.

- Very Brief Advice: Ask about tobacco smoking and record in notes; Advise on how best to stop; ACT: direct to best available support and treatment to help them quit.

- Find out more here: https://www.ipcrg.org/themes/tobacco-dependence and https://www.pcrs-uk.org/sites/default/files/tobacco_dependency_pragmatic...

- The good news about the VBA framework is you can use for other behaviours too see https://www.who.int/europe/publications/i/item/9789289058551

- Studies are underway to see if it also works for chewed tobacco - a major issue in South Asia where colourful packs are sold to young children

- Most e-cigarettes contain nicotine but not tobacco

- Some people do not want to quit nicotine or the habit of "smoking" and therefore find e-cigarettes a safer alternative

- Some find they can gradually quit using e-cigarettes

- The latest Cochrane "living" (ie updated whenever there is significant new evidence) report 2022 suggests e-cigarettes are therefore a useful quitting tool (see earlier posts)

- This is completely different from people who have not previously smoked or chewed tobacco in any form taking up e-cigarettes. Clearly they are now introducing something addictive into their lives which wasn't there before. So it's a question of weighing up the benefit and harm.

I welcome comment/correction!

Thanks

Siân

HIFA profile: Sian Williams is Chief Executive Officer at the International Primary Care Respiratory Group in the UK. Professional interests: Implementation science, NCDs, primary care, respiratory health, education, evaluation, value, breaking down silos. sian.health AT gmail.com